NO20025209D0 - Cyklipostiner, deres fremstilling og anvendelse - Google Patents

Cyklipostiner, deres fremstilling og anvendelse

Info

Publication number
NO20025209D0
NO20025209D0 NO20025209A NO20025209A NO20025209D0 NO 20025209 D0 NO20025209 D0 NO 20025209D0 NO 20025209 A NO20025209 A NO 20025209A NO 20025209 A NO20025209 A NO 20025209A NO 20025209 D0 NO20025209 D0 NO 20025209D0
Authority
NO
Norway
Prior art keywords
physiologically compatible
cyclipostins
compounds
relates
chemical equivalents
Prior art date
Application number
NO20025209A
Other languages
English (en)
Other versions
NO20025209L (no
NO330438B1 (no
Inventor
Lsszlo Vurtesy
Klaus Ehrlich
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20025209D0 publication Critical patent/NO20025209D0/no
Publication of NO20025209L publication Critical patent/NO20025209L/no
Publication of NO330438B1 publication Critical patent/NO330438B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20025209A 2000-05-04 2002-10-30 Cyklipostiner, deres fremstilling og anvendelse samt farmasoytisk preparat og mikroorganisme NO330438B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (de) 2000-05-04 2000-05-04 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
PCT/EP2001/004652 WO2001083497A1 (de) 2000-05-04 2001-04-25 Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben

Publications (3)

Publication Number Publication Date
NO20025209D0 true NO20025209D0 (no) 2002-10-30
NO20025209L NO20025209L (no) 2002-10-30
NO330438B1 NO330438B1 (no) 2011-04-11

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025209A NO330438B1 (no) 2000-05-04 2002-10-30 Cyklipostiner, deres fremstilling og anvendelse samt farmasoytisk preparat og mikroorganisme

Country Status (28)

Country Link
EP (1) EP1280812B1 (no)
JP (1) JP5038572B2 (no)
KR (1) KR100779867B1 (no)
CN (1) CN1216890C (no)
AR (1) AR028398A1 (no)
AT (1) ATE288442T1 (no)
AU (2) AU2001262229B2 (no)
BR (1) BR0110459A (no)
CA (1) CA2407808C (no)
CZ (1) CZ20023547A3 (no)
DE (2) DE10021731B4 (no)
DK (1) DK1280812T3 (no)
EE (1) EE05090B1 (no)
ES (1) ES2236234T3 (no)
HK (1) HK1055745A1 (no)
HR (1) HRP20020864A2 (no)
HU (1) HUP0300306A3 (no)
IL (2) IL152612A0 (no)
MX (1) MXPA02010297A (no)
NO (1) NO330438B1 (no)
NZ (1) NZ522352A (no)
PL (1) PL358328A1 (no)
PT (1) PT1280812E (no)
RU (1) RU2266911C2 (no)
SK (1) SK15602002A3 (no)
WO (1) WO2001083497A1 (no)
YU (1) YU81502A (no)
ZA (1) ZA200208928B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372495T3 (es) 2003-11-13 2012-01-20 Hanmi Holdings Co., Ltd Método para la producción en masa de la región constante de inmunoglobulina.
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
EP1894601A1 (en) 2006-08-29 2008-03-05 sanofi-aventis Treating mycobacterial infections with cyclipostins
KR200453850Y1 (ko) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 수질 관리 센서 내장형 수도미터기
KR102073748B1 (ko) 2013-01-31 2020-02-05 한미약품 주식회사 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
AR096891A1 (es) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤

Also Published As

Publication number Publication date
ATE288442T1 (de) 2005-02-15
HK1055745A1 (en) 2004-01-21
JP2003531914A (ja) 2003-10-28
CA2407808C (en) 2013-06-25
MXPA02010297A (es) 2003-04-25
BR0110459A (pt) 2003-03-11
KR100779867B1 (ko) 2007-11-27
ES2236234T3 (es) 2005-07-16
NO20025209L (no) 2002-10-30
HRP20020864A2 (en) 2004-12-31
CN1216890C (zh) 2005-08-31
CA2407808A1 (en) 2002-10-30
CN1427845A (zh) 2003-07-02
EP1280812A1 (de) 2003-02-05
EE200200599A (et) 2004-04-15
YU81502A (sh) 2006-05-25
ZA200208928B (en) 2003-10-07
IL152612A0 (en) 2003-06-24
SK15602002A3 (sk) 2003-04-01
HUP0300306A3 (en) 2004-10-28
DK1280812T3 (da) 2005-05-30
EE05090B1 (et) 2008-10-15
AR028398A1 (es) 2003-05-07
DE10021731B4 (de) 2005-12-08
CZ20023547A3 (cs) 2003-02-12
HUP0300306A2 (hu) 2003-06-28
NO330438B1 (no) 2011-04-11
WO2001083497A1 (de) 2001-11-08
JP5038572B2 (ja) 2012-10-03
PL358328A1 (en) 2004-08-09
RU2266911C2 (ru) 2005-12-27
IL152612A (en) 2009-11-18
AU2001262229B2 (en) 2007-01-25
NZ522352A (en) 2004-06-25
DE50105249D1 (de) 2005-03-10
AU6222901A (en) 2001-11-12
DE10021731A1 (de) 2001-11-15
EP1280812B1 (de) 2005-02-02
PT1280812E (pt) 2005-05-31
KR20030009464A (ko) 2003-01-29

Similar Documents

Publication Publication Date Title
SE0200920D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
SE0103836D0 (sv) Novel compounds
NO20024772D0 (no) Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel
BR0108678A (pt) Novos compostos
BR0212876A (pt) Concentrado em suspensão, composição herbicida e métodos de aplicar uma composição herbicida e de preparar um concentrado em suspensão e uma composição herbicida
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
BR0316375A (pt) Diazinopirimidinas
NO20024177L (no) Farmasöytiske preparater inneholdende azetidinderivater, de nye azetidinderivater og deres fremstilling
IS6658A (is) Ný efnasambönd
SE0300480D0 (sv) Novel compounds
IL168718A (en) Biguanide derivatives, compositions comprising the derivatives, process for preparing an antimicrobial compound and use of the derivatives in the preparation of medicaments
SE0302192D0 (sv) Novel compounds
ATE300541T1 (de) Pyrazolopyridinderivate
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
BR0213066A (pt) Compostos de cianoacetila
EE200000472A (et) Kasvajavastased toimeained
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
NO20025209D0 (no) Cyklipostiner, deres fremstilling og anvendelse
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
MXPA04004621A (es) Nucleotidos, preparaciones de los mismos y su utilizacion como inhibidores de polimerasas virales de arn.
MXPA04005809A (es) Inhibidores de proteinas quinasas.
SE0202693D0 (sv) Compounds
SE0102057D0 (sv) New Salts I

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees